An evidence-based treatment algorithm for tendinopathy covering first-line load management and eccentric exercise through third-line PRP, BPC-157, and surgical referral, with citations to primary RCTs and society guidelines.
A guide to stopping testosterone replacement therapy for male hypogonadism safely, including tapering protocols, HPG axis recovery, and monitoring schedules backed by Endocrine Society guidelines.
Learn exactly how to prepare for your first clinical visit about menopause-related weight gain, what labs to request, which symptoms to track, and how HRT and GLP-1 medications fit into the treatment plan.
Menopause-related weight gain is frequently misattributed to aging or lifestyle alone. Learn which diagnoses are commonly missed, how to distinguish them, and what evidence-based treatments actually work.
A stage-by-stage guide to the real costs of perimenopause care, from early irregular cycles through late-stage vasomotor symptoms, including medication costs, lab work, and when to seek specialist care.
A review of mechanistic research beyond LDL-lowering in established cardiovascular disease, covering inflammation, clonal hematopoiesis, gut microbiome signaling, Lp(a), and GLP-1 receptor agonists, with notes on evidence strength and what remains unproven.
A clinical deep-dive into rare and atypical presentations of male hypogonadism, including fertile eunuch syndrome, Kallmann syndrome variants, late-onset hypogonadism without classic symptoms, and medication-induced forms, with primary-source citations and practical diagnostic guidance.
A clinically detailed guide to the uncommon and misdiagnosed faces of menopause, including rare vasomotor variants, neurological symptoms, skin and joint changes, and premature ovarian insufficiency, with primary-source citations and guidance.
A deep dive into the latest science on why menopause drives weight gain, covering estrogen signaling, hypothalamic changes, gut microbiome shifts, brown adipose tissue dysfunction, and GLP-1 receptor interactions.
How common is metabolic syndrome worldwide? Epidemiology data, regional breakdowns, rising trends, diagnostic criteria, and clinical guidance from primary sources.
Metabolic syndrome affects 1 in 3 U.S. Adults and generates hundreds of billions in annual healthcare costs. This guide covers the economic burden, racial and income disparities, productivity losses, and evidence-based interventions that reduce both health and financial harm.
A clinical history of NAFLD and MASLD treatment from the 1980s to today, covering lifestyle interventions, vitamin E, pioglitazone, and the first FDA-approved therapy resmetirom, with primary-source citations throughout.
A comprehensive clinical review of racial and ethnic disparities in NAFLD / MASLD prevalence, severity, genetics, and treatment access, with primary-source citations and guidance.
A clinical deep-dive into why Black, Hispanic, Native American, and Pacific Islander adults carry a disproportionate burden of obesity, what drives those gaps, and how current guidelines address them.
A deep dive into the latest OSA mechanism research: loop gain, arousal threshold, upper-airway muscle dysfunction, hypoxic signaling, and GLP-1 pathway discoveries that are reshaping treatment strategy.
A comprehensive clinical history of obstructive sleep apnea treatment from tracheotomy in the 1960s through CPAP, oral appliances, surgery, and the emerging GLP-1 era, with primary-source citations throughout.
Black, Hispanic, Asian, and Native American populations face higher OSA prevalence, later diagnosis, and worse outcomes than white patients. Learn what drives these gaps and what clinicians can do.
A deep look at the emerging biological mechanisms driving perimenopause, including neuroinflammation, mitochondrial dysfunction, and kisspeptin signaling, with primary-source citations and clinical implications.
1.1 mil millones de mujeres estarán en o tras la transición menopáusica para 2025, con 47 millones entrando en perimenopausia cada año.
A look at the most contested questions in post-surgical recovery, from opioid-sparing protocols to optimal nutrition timing, with primary-source citations and practical guidance.
A clinical review of racial and ethnic disparities in post-surgical recovery, covering pain management, complication rates, readmission, and evidence-based strategies to close the gap.
A deep dive into the socioeconomic impact of post-surgical recovery, covering direct medical costs, lost productivity, caregiver burden, and disparities in recovery outcomes across income and insurance strata.
A clinically rigorous review of the most contested debates in prediabetes research: diagnostic thresholds, reversal definitions, treatment with metformin, overdiagnosis risk, and what current guidelines actually recommend.
A clinical deep-dive into how prediabetes treatment has evolved from lifestyle-only advice in the 1980s through modern pharmacotherapy and precision medicine, with primary-source citations and actionable guidance.
Why prediabetes rates differ sharply by race and ethnicity, which populations carry the highest burden, and what ADA and USPSTF guidelines recommend for equitable screening and treatment.
A clinical review of racial and ethnic disparities in secondary hypogonadism diagnosis, treatment access, and outcomes, with primary-source citations and actionable clinical guidance.
A review of the most contested clinical questions in tendinopathy management, from diagnosis and pathology staging to loading protocols, injections, biologics, and surgery thresholds, with an honest account of where the evidence is solid and where it is not.
An evidence-based review of the emerging biological mechanisms driving tendinopathy, including neurogenic inflammation, failed healing responses, metabolic drivers, and new therapeutic targets backed by primary-source research.
A clinical overview of the socioeconomic burden of tendinopathy, covering direct medical costs, productivity losses, disability rates, and evidence-based management strategies that reduce long-term expenses.
A comprehensive, evidence-based review of how race and ethnicity shape type 2 diabetes risk, diagnosis, complications, and treatment access, with primary-source citations throughout.
A clinically grounded review of the socioeconomic burden of type 2 diabetes, direct medical costs, lost productivity, racial and income disparities, and actionable strategies backed by primary trial and guideline data.
Does Farxiga (dapagliflozin) reduce appetite or change food cravings? A PharmD/MD-level review of the mechanisms, clinical trial data, and what patients can realistically expect.
A clinical deep-dive into how dapagliflozin (Farxiga) affects mental health, mood, depression risk, and quality of life. Covers DAPA-HF, DAPA-CKD, and emerging mechanistic data with physician-level citations.
A clinician-level review of how dapagliflozin (Farxiga) affects sleep architecture, nocturia, OSA-related outcomes, and cardiorespiratory physiology, with primary-literature citations.
A deep-dive into denosumab (Prolia) and cognition: RANKL biology, FREEDOM trial data, pharmacovigilance signals, and clinical decision-making for patients concerned about brain fog or cognitive decline.
A comprehensive clinical guide to the denosumab pre-surgery hold window, covering fracture rebound risk, optimal timing, bridging strategies, and evidence-based protocols for perioperative management of Prolia patients.
Randomized trials from 2011-2015 show myo-inositol restores ovulation in up to 62% of PCOS patients versus 27% on placebo, rivaling metformin.
A deep dive into the bidirectional relationship between chronic low-grade inflammation, weight gain, insulin resistance, and metabolic disease, with specific clinical data, named trials, and actionable guidance.
Board-reviewed guide covering daily fiber targets by age and sex, the difference between soluble and insoluble fiber, blood sugar effects, and practical food sources with serving sizes.
GLP-1 receptor agonists drive significant weight loss, but up to 40% of that lost weight can be lean mass. This evidence-based guide covers protein targets, resistance training protocols, and clinical strategies to protect muscle while on semaglutide or tirzepatide.
A complete guide to PCOS diagnosis: which blood tests, imaging, and clinical criteria doctors use, what normal and abnormal results mean, and how to prepare for each step.
Glimepiride is an oral sulfonylurea for type 2 diabetes that boosts insulin release, lowering A1C by 1 to 2 points but risking hypoglycemia.
Sudden, constant hunger in your 40s or 50s is often tied to perimenopause-driven hormone shifts. Learn the biology, the red flags, and what the evidence actually supports.
A clinically detailed explanation of why menopause causes weight gain, covering estrogen loss, metabolic slowdown, cortisol, sleep, and evidence-based treatments including HRT and GLP-1 agonists.
After menopause, estrogen loss redirects fat storage into the abdomen, where it is linked to inflammation, insulin resistance, and cardiovascular risk. This article explains the mechanisms, distinguishes established evidence from areas needing verification, and outlines what a reader can realistically act on.
Processed foods disrupt gut microbiome diversity, trigger chronic low-grade inflammation, and hijack appetite-regulating hormones. Learn the specific mechanisms, the clinical evidence, and what dietary changes actually move the needle.
PCOS runs in families, but the inheritance pattern is complex. Learn what genetic research, twin studies, and candidate gene data tell us about your family risk and what to do about it.
A guide to the best fiber supplements for menopausal women, covering types, doses, clinical evidence, and how fiber affects blood sugar, weight, and cardiovascular risk during the menopause transition.
A complete guide to Cigna coverage for Trulicity (dulaglutide), including formulary tier, prior authorization criteria, step therapy requirements, denial appeals, and manufacturer savings options.
A guide to dulaglutide (Trulicity) overdose: symptoms, mechanisms, treatment protocols, and when to seek emergency care.
A comparison of compounded dulaglutide versus branded Trulicity, covering FDA approval status, clinical trial evidence from REWIND, safety differences, cost, and who qualifies for each option.
A clinical deep-dive into how dulaglutide (Trulicity) affects liver enzymes, hepatic fat, and NAFLD/MASH. Covers REWIND trial data, ALT/AST findings, and prescribing guidance for patients with liver disease.
Stopping dulaglutide (Trulicity) can trigger glycemic rebound, weight regain, and loss of cardiovascular protection. Learn what the clinical evidence supports, what remains unverified, and how to plan a discontinuation with your care team.
A careful look at how dulaglutide (Trulicity) plausibly affects sleep, including GLP-1 receptor biology, nausea-related sleep disruption during titration, and the indirect route from weight loss to obstructive sleep apnea improvement. Notes where dedicated polysomnography evidence does not exist.
A guide to dutasteride (Avodart) safety in adults aged 30, 49, covering sexual side effects, cardiovascular signals, cancer risk, drug interactions, and how to weigh risks against benefits for BPH and hair loss.
Does dutasteride (Avodart) change appetite or food cravings? A deep dive into the pharmacology, clinical trial data, and patient reports around dutasteride and appetite.
A deep dive into dutasteride (Avodart) and long-term cardiovascular risk, covering the REDUCE trial, PCPT-era data, MACE signals, lipid effects, and current prescribing guidance for men on 5-alpha-reductase inhibitor therapy.
Find out whether Cigna covers Avodart (dutasteride) for BPH and hair loss, what prior-authorization criteria apply, how step therapy works, and how to appeal a denial.
A clinical guide to dutasteride (Avodart) monitoring in adults 65 and older, covering falls risk, renal considerations, drug interactions, PSA interpretation, and deprescribing thresholds.
A deep dive into dutasteride (Avodart) and its effects on mood, depression, anxiety, libido, and cognitive function, with primary-literature citations and clinical guidance.